Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

Healthcare companies such as GSK plc and tech companies such as Siemens AG were among the top losers on European markets on ...

A COMMON drug prescribed to treat restless leg syndrome and Parkinson’s can trigger disturbing side effects, experts have ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

Dopamine-receptor agonists, used to treat Parkinson's disease and restless legs syndrome, have been linked to impulse-control disorders like hypersexuality and compulsive gambling. Studies highlight ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

The Trump administration is swinging tariff threats against allies and adversaries alike, and international stocks are ...